Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology

被引:121
|
作者
Hehir, Michael K. [1 ]
Silvestri, Nicholas J. [2 ]
机构
[1] Univ Vermont, Larner Coll Med, Dept Neurosci, 1 South Prospect St, Burlington, VT 05401 USA
[2] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, 1010 Main St, Buffalo, NY 14202 USA
关键词
Myasthenia gravis; Acetylcholine receptor; Antimuscle-specific kinase; Occular; RYANODINE RECEPTOR ANTIBODIES; DIAGNOSIS; AUTOANTIBODIES; CHILDHOOD; RITUXIMAB; MANAGEMENT; CHILDREN; FEATURES; TRIAL;
D O I
10.1016/j.ncl.2018.01.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myasthenia gravis (MG) is a rare disease but the most common disorder of the neuromuscular junction. It is the prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine receptor (AChR) leading to characteristic fatigable weakness of the ocular, bulbar, respiratory, axial, and limb muscles. The majority of patients with MG first present with ocular symptoms. Most patients with MG experience at least 1 exacerbation of symptoms throughout the course of their illness. This article covers the epidemiology, clinical presentation, classification, and natural history of MG.
引用
收藏
页码:253 / +
页数:9
相关论文
共 50 条
  • [1] Ocular presentation of myasthenia gravis: A natural history cohort
    Kamarajah, Sivesh K.
    Sadalage, Girija
    Palmer, Jonathan
    Carley, Helena
    Maddison, Paul
    Sivaguru, Arulmaran
    MUSCLE & NERVE, 2018, 57 (04) : 622 - 627
  • [2] OCULAR PRESENTATION OF MYASTHENIA GRAVIS: AN AUDIT AND NATURAL HISTORY COHORT
    Kamarajah, Sivesh Kathir
    Sadalage, Girija
    Palmer, Jonathan
    Carley, Helena
    Maddison, Paul
    Sivaguru, Arulmaran
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [3] Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
    Dresser, Laura
    Wlodarski, Richard
    Rezania, Kourosh
    Soliven, Betty
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [4] Forehead Tremor: A Clinical Presentation of Myasthenia Gravis?
    Giorgia, Sciacca
    Ester, Reggio
    Giulia, Donzuso
    Alessandra, Nicoletti
    Filippo, Drago
    Salvatore, Salomone
    Mario, Zappia
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (02): : 225 - 226
  • [5] MYASTHENIA-GRAVIS - CLINICAL AND NEUROLOGICAL PRESENTATION
    STERN, G
    THORAX, 1978, 33 (05) : 671 - 672
  • [6] The epidemiology of myasthenia gravis
    Phillips, LH
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 407 - 412
  • [7] The epidemiology of myasthenia gravis
    Phillips, LH
    SEMINARS IN NEUROLOGY, 2004, 24 (01) : 17 - 20
  • [8] Diagnostic and clinical classification of autoimmune myasthenia gravis
    Berrih-Aknin, Sonia
    Frenkian-Cuvelier, Melinee
    Eymard, Bruno
    JOURNAL OF AUTOIMMUNITY, 2014, 48-49 : 143 - 148
  • [9] EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS OF MYASTHENIA GRAVIS PATIENTS IN CHINA
    Liu, W-B
    Fang, W.
    Li, Y.
    Mo, R.
    Huang, X.
    MUSCLE & NERVE, 2015, 52 : S138 - S138
  • [10] Myasthenia gravis as a form of clinical presentation of thymic carcinoma
    Joana Espiga de Macedo
    Sílvia Lopes
    Helena Gouveia
    Sofia Oliveira
    Joo Cunha
    Ana Luísa Faria
    Sónia Rego
    Albino Oliveira
    Luís Krug
    Emílio Macias Bravo
    World Journal of Respirology, 2015, (02) : 176 - 179